STOCKHOLM, March 25, 2025 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi. According to Eisai’s simulation, Leqembi sales will reach JPY 250 to 280 billion for…
